|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
3
|
Cai Y and Sablina AA: Cancer-associated
chromosomal deletions: Size makes a difference. Cell Cycle.
15:2850–2851. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pezzolo A, Sementa AR, Lerone M, Morini M,
Ognibene M, Defferrari R, Mazzocco K, Conte M, Gigliotti AR,
Garaventa A, et al: Constitutional 3p26.3 terminal microdeletion in
an adolescent with neuroblastoma. Cancer Biol Ther. 18:285–289.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Togo Y, Yoshikawa Y, Suzuki T, Nakano Y,
Kanematsu A, Zozumi M, Nojima M, Hirota S, Yamamoto S and
Hashimoto-Tamaoki T: Genomic profiling of the genes on chromosome
3p in sporadic clear cell renal cell carcinoma. Int J Oncol.
48:1571–1580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riquelme E, Tang M, Baez S, Diaz A, Pruyas
M, Wistuba II and Corvalan A: Frequent epigenetic inactivation of
chromosome 3p candidate tumor suppressor genes in gallbladder
carcinoma. Cancer Lett. 250:100–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuroki T, Tajima Y, Matsuo K and Kanematsu
T: Genetic alterations in gallbladder carcinoma. Surg Today.
35:101–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Penkov D, Ni R, Else C, Piñol-Roma S,
Ramirez F and Tanaka S: Cloning of a human gene closely related to
the genes coding for the c-myc single-strand binding proteins.
Gene. 243:27–36. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niki T, Galli I, Ariga H and Iguchi-Ariga
SM: MSSP, a protein binding to an origin of replication in the
c-myc gene, interacts with a catalytic subunit of DNA polymerase
alpha and stimulates its polymerase activity. FEBS Lett.
475:209–212. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niki T, Izumi S, Saëgusa Y, Taira T, Takai
T, Iguchi-Ariga SM and Ariga H: MSSP promotes ras/myc cooperative
cell transforming activity by binding to c-Myc. Genes Cells.
5:127–141. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Chen L, Nie CJ, Zeng TT, Liu H, Mao
X, Qin Y, Zhu YH, Fu L and Guan XY: Downregulation of RBMS3 is
associated with poor prognosis in esophageal squamous cell
carcinoma. Cancer Res. 71:6106–6115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu Y, Yun D, Zhao Y, Wang Y, Sun R, Yan Q,
Zhang S, Lu M, Zhang Z, Lu D and Li Y: Down regulation of RNA
binding motif, single-stranded interacting protein 3, along with up
regulation of nuclear HIF1A correlates with poor prognosis in
patients with gastric cancer. Oncotarget. 8:1262–1277. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Y, Quan L and Ling Y: RBMS3 inhibits
the proliferation and metastasis of breast cancer cells. Oncol Res.
26:9–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang YN, Liu Y, Meng Q, Li X, Wang F, Yao
G, Wang L, Fu S and Tong D: RBMS3 is a tumor suppressor gene that
acts as a favorable prognostic marker in lung squamous cell
carcinoma. Med Oncol. 32:4592015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen J, Kwong DL, Zhu CL, Chen LL, Dong
SS, Zhang LY, Tian J, Qi CB, Cao TT, Wong AM, et al: RBMS3 at 3p24
inhibits nasopharyngeal carcinoma development via inhibiting cell
proliferation, angiogenesis, and inducing apoptosis. PLoS One.
7:e446362012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y,
Zhang T, Khaliq J and Li Y: miR-140-5p suppresses the
proliferation, migration and invasion of gastric cancer by
regulating YES1. Mol Cancer. 16:1392017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun R, Wu J, Chen Y, Lu M, Zhang S, Lu D
and Li Y: Down regulation of Thrombospondin2 predicts poor
prognosis in patients with gastric cancer. Mol Cancer. 13:2252014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang S, Lu M, Chen Y, Meng D, Sun R, Yun
D, Zhao Z, Lu D and Li Y: Overexpression of eukaryotic elongation
factor 1 alpha-2 is associated with poorer prognosis in patients
with gastric cancer. J Cancer Res Clin Oncol. 141:1265–1275. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng D, Chen Y, Yun D, Zhao Y, Wang J, Xu
T, Li X, Wang Y, Yuan L, Sun R, et al: High expression of N-myc
(and STAT) interactor predicts poor prognosis and promotes tumor
growth in human glioblastoma. Oncotarget. 6:4901–4919. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang ZH, Li Z, Hu M, Yang QJ, Yan S, Wu
RS, Li BA and Guo M: Ovol2 gene inhibits the
epithelial-to-mesenchymal transition in lung adenocarcinoma by
transcriptionally repressing Twist1. Gene. 600:1–8. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu JD, Song LJ, Yan DJ, Feng YY, Zang YG
and Yang Y: Caffeine inhibits the growth of glioblastomas through
activating the caspase-3 signaling pathway in vitro. Eur Rev Med
Pharmacol Sci. 19:3080–3088. 2015.PubMed/NCBI
|
|
24
|
Tang L, Tan YX, Jiang BG, Pan YF, Li SX,
Yang GZ, Wang M, Wang Q, Zhang J, Zhou WP, et al: The prognostic
significance and therapeutic potential of hedgehog signaling in
intrahepatic cholangiocellular carcinoma. Clin Cancer Res.
19:2014–2024. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen Y, Wang X, Xu J and Lu L: SerpinE2, a
poor biomarker of endometrial cancer, promotes the proliferation
and mobility of EC cells. Cancer Biomark. 19:271–278. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wigerup C, Påhlman S and Bexell D:
Therapeutic targeting of hypoxia and hypoxia-inducible factors in
cancer. Pharmacol Ther. 164:152–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang G, Miyake M, Lawton A, Goodison S
and Rosser CJ: Matrix metalloproteinase-10 promotes tumor
progression through regulation of angiogenic and apoptotic pathways
in cervical tumors. BMC Cancer. 14:3102014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ruan K, Song G and Ouyang G: Role of
hypoxia in the hallmarks of human cancer. J Cell Biochem.
107:1053–1062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okita S, Kondoh S, Shiraishi K, Kaino S,
Hatano S and Okita K: Expression of vascular endothelial growth
factor correlates with tumor progression in gallbladder cancer. Int
J Oncol. 12:1013–1018. 1998.PubMed/NCBI
|
|
30
|
Yano S, Muguruma H, Matsumori Y, Goto H,
Nakataki E, Edakuni N, Tomimoto H, Kakiuchi S, Yamamoto A, Uehara
H, et al: Antitumor vascular strategy for controlling experimental
metastatic spread of human small-cell lung cancer cells with ZD6474
in natural Killer cell-depleted severe combined immunodeficient
mice. Clin Cancer Res. 11:8789–8798. 2006. View Article : Google Scholar
|
|
31
|
Davidoff AM, Ng CY, Zhang Y, Streck CJ,
Mabry SJ, Barton SH, Baudino T, Zhou J, Kerbel RS, Vanin EF and
Nathwani AC: Careful decoy receptor titering is required to inhibit
tumor angiogenesis while avoiding adversely altering VEGF
bioavailability. Mol Ther. 11:300–310. 2005. View Article : Google Scholar : PubMed/NCBI
|
